3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
6
Unknown
3
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Ovarian Neoplasms
7
Fallopian Tube Neoplasms
6
Breast Neoplasms
6
Neoplasms
4
Sarcoma
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Lymphoma, B-Cell
2
Sarcoma, Kaposi
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Primary Effusion
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Lymphadenopathy
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Kidney Neoplasms
1
Invasive Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
HIV Infections
1
Glioma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Interventions
Rituximab
32
Cyclophosphamide
28
Lenalidomide
19
Prednisone
16
Doxorubicin
16
Vincristine
14
Etoposide
11
CT-P10
11
Gemcitabine
9
polatuzumab vedotin
8
Oxaliplatin
7
ibrutinib
6
glofitamab
6
fludarabine
6
acalabrutinib
6
Magnetic Resonance Spectroscopy
6
Ifosfamide
6
Carboplatin
6
tafasitamab
5
prednylidene
5
pembrolizumab
5
obinutuzumab
5
deltacortene
5
Specimen Handling
5
R-CHOP protocol
5
Nivolumab
5
Biopsy
5
venetoclax
4
fludarabine phosphate
4
selinexor
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Lymphoma, Large B-Cell, Diffuse
×
liposomal doxorubicin
×
Clear all
NCT02734771
2025-08-12
BV mini CHP
University of Rochester
Phase 2
Active not recruiting
24 enrolled